CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 31 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $800,000 | -60.7% | 1,000,000 | -52.9% | 0.01% | -52.6% |
| Q2 2018 | $2,035,000 | +855.4% | 2,121,505 | +1703.7% | 0.02% | +850.0% |
| Q1 2018 | $213,000 | -34.7% | 117,618 | -46.2% | 0.00% | -33.3% |
| Q4 2017 | $326,000 | -29.7% | 218,679 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $464,000 | +53.1% | 218,679 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $303,000 | -14.4% | 214,773 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $354,000 | -56.2% | 221,281 | -1.2% | 0.00% | -57.1% |
| Q4 2016 | $808,000 | -33.5% | 223,885 | +13.5% | 0.01% | -36.4% |
| Q3 2016 | $1,215,000 | +273.8% | 197,200 | +390.3% | 0.01% | +175.0% |
| Q3 2015 | $325,000 | -73.4% | 40,220 | -59.8% | 0.00% | -42.9% |
| Q2 2015 | $1,222,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $4,572,000 | 5.05% |
| Clarus Ventures, LLC | 2,752,488 | $4,404,000 | 3.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 388,030 | $621,000 | 0.12% |
| Rhenman & Partners Asset Management AB | 310,756 | $497,000 | 0.08% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $39,000 | 0.01% |
| OPPENHEIMER & CO INC | 90,000 | $144,000 | 0.00% |
| Alyeska Investment Group, L.P. | 221,281 | $354,000 | 0.00% |
| A.R.T. Advisors, LLC | 46,747 | $74,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,347 | $162,000 | 0.00% |
| Acrospire Investment Management LLC | 680 | $1,000 | 0.00% |